1. Zou, Dao-Pei, Chen, Yang-Mei, Zhang, Ling-Zhao, Gao, Tian-Wen, Chen, Jin. 2020. SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling. In Genes & diseases, 8, 677-688. doi:10.1016/j.gendis.2020.06.003. https://pubmed.ncbi.nlm.nih.gov/34291139/
2. Mahmoud, Dorra Elhaj, Kaabachi, Wajih, Sassi, Nadia, Cheour, Elhem, Laadhar, Lilia. 2021. SFRP5 Enhances Wnt5a Induced-Inflammation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. In Frontiers in immunology, 12, 663683. doi:10.3389/fimmu.2021.663683. https://pubmed.ncbi.nlm.nih.gov/34211463/
3. Wang, Rui, Hong, Jie, Liu, Ruixin, Wang, Weiqing, Ning, Guang. 2014. SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. In Journal of molecular endocrinology, 53, 405-15. doi:10.1530/JME-14-0037. https://pubmed.ncbi.nlm.nih.gov/25324487/
4. Wang, H, Wang, X, Hu, R, Zhang, J, Liu, Z. 2014. Methylation of SFRP5 is related to multidrug resistance in leukemia cells. In Cancer gene therapy, 21, 83-9. doi:10.1038/cgt.2013.87. https://pubmed.ncbi.nlm.nih.gov/24434572/